Who owns AGIO?
Institutional ownership of Agios Pharmaceuticals Inc. from Form 13F, Q2 2026
238 institutional managers reported holding Agios Pharmaceuticals Inc. (AGIO) in Form 13F filings for Q2 2026, with 66,108,749 shares worth $2.5B. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 3,043,404 shares (+4.8%). 36 opened new positions and 31 sold out.
- Funds holding
- 238
- Value held
- $2.5B
- New / sold out
- 36 / 31
- Net shares, same filers
- +4.8%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of AGIO
Share of 13F holdings is each fund's shares as a share of the 66,108,749 AGIO shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- ADAR1 Capital Management, LLC Added+$42.6M
- UBS Group AG Added+$31.7M
- Lynx1 Capital Management LP Added+$29.6M
- BlackRock, Inc. Added+$26.0M
- AQR Capital Management LLC Added+$24.0M
- Nomura Asset Management International Inc. Added+$22.9M
- Arrowstreet Capital, Limited Partnership Added+$20.8M
- Defilade Capital Management, L.P. New+$20.3M
- Point72 Asset Management, L.P. New+$18.8M
- D. E. Shaw & Co., Inc. Added+$15.8M
Biggest sellers in Q2 2026
- T. Rowe Price Investment Management, Inc. Sold out-$50.4M
- MPM Bioimpact LLC Sold out-$44.2M
- Frazier Life Sciences Management, L.P. Sold out-$42.5M
- Wellington Management Group LLP Trimmed-$23.0M
- Erste Asset Management GmbH Trimmed-$20.9M
- Artisan Partners Limited Partnership Sold out-$16.3M
- Vestal Point Capital, LP Sold out-$15.2M
- Armistice Capital, LLC Trimmed-$11.7M
- Marshall Wace, LLP Trimmed-$11.5M
- BNP PARIBAS ASSET MANAGEMENT Holding S.A. Trimmed-$11.2M
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $475M and sold $343M; 96 added and 63 trimmed.
Schedule 13D and 13G filings on AGIO
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-11-13MORGAN STANLEY SCHEDULE 13G filed by Agios Pharmaceuticals Inc.Schedule 13G
- 2026-07-02D. E. SHAW & CO, L.P. SCHEDULE 13G filed by Agios Pharmaceuticals Inc.Schedule 13G
- 2026-05-06Lynx1 Capital Management LP SCHEDULE 13G filed by Agios Pharmaceuticals Inc.Schedule 13G
- 2026-02-09STATE STREET CORP SCHEDULE 13G filed by Agios Pharmaceuticals Inc.Schedule 13G
- 2025-07-07Bellevue Group AG SCHEDULE 13G filed by Agios Pharmaceuticals Inc.Schedule 13G
Questions about AGIO ownership
- Who owns AGIO stock?
- 238 institutional investment managers reported AGIO positions in their Form 13F filings for Q2 2026, holding 66,108,749 shares worth $2.5B in total. BlackRock, Inc. reported the largest position.
- Are funds buying or selling AGIO?
- In Q2 2026, 36 managers opened new AGIO positions, 96 added, 63 trimmed and 31 sold out. Managers that filed in both quarters added a net 3,043,404 shares.
- How current is this AGIO institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to AGIO by CUSIP. Options are left out. AGIO news and filings · AGIO insider trades · Top funds